ADHD

Gambling

Opioid Related Disorders

Alcohol Abuse

Amphetamine Related Disorders

Substance Use Disorder

Addiction & Substance Use

Disaster Psychiatry

Panic Disorder

PTSD

Trauma And Violence

Traumatic Stress Disorders

Anxiety & Stress Disorders

Mania

Bipolar Disorder

Bipolar I Disorder

COVID-19

Cannabis

Case Discussions

Comorbidity

Compulsive Disorders

Cultural Psychiatry

Dysthymia

Electroconvulsive Therapy

Major Depressive Disorder

Depression

Digital Psychiatry

Digital Therapeutics

Eating Disorders

Ethics

Munchausen Syndrome

Sexual Offenses

Forensic Psychiatry

Impulse Control Disorder

Integrative Psychiatry

International Overdose Awareness

Mental Health Systems

Mood Disorders

Cognitive Disorders

Dementia

Alzheimer Disease

Autism

Neuropsychiatry

Pain

Compulsive Personality Disorder

Dependent Personality Disorder

Dissociative Identity Disorder

Histrionic Personality Disorder

Schizoid Personality Disorder

Antisocial Personality Disorder

Borderline Personality

Personality Disorders

Psychedelics

Psychiatric Emergencies

Psychopharmacology

Delirium

Metabolic Disorders

Somatoform Disorder

Psychosomatics

Cognitive Behavioral Therapy

Psychotherapy

Paranoid Schizophrenia

Psychotic Affective Disorders

Schizoaffective

Schizophrenia Psychotic Features

Schizotypal Personality Disorder

Tardive Dyskinesia

Catatonic Schizophrenia

Schizophrenia/Psychosis

Masochism

Sexual Addiction

Sexual & Sexuality

Nocturnal Paroxysmal Dystonia

Sleep Deprivation

Sleep Wake Transition

Circadian Rhythm Sleep Disorders

Sleep Disorders

Pervasive Developmental Disorder

Diversity Reflections

Gender Issues

Geriatric Psychiatry

Military Mental Health

Child & Adolescent Psychiatry

Special Populations

Suicide

Transcranial Magnetic Stimulation

News

Media

Around the Practice

Between the Lines

PsychView

Expert Perspectives

Case-Based Psych Perspectives

Medical World News

Payer-Provider Perspective

Slideshows

Videos

Viewpoints

Webinars

Publications

Psychiatric Times

All Publications

Partner Perspectives

Job Board

CME/CE

Partners

Resources

Clinical Scales

Conference Coverage

Conference Listing

Interactive Tools

Quizzes

Series

Special Reports

Tipsheets

Toolkits

Subscribe

Print Subscription

eNewsletter

Articles

"And when they bombed other people’s houses, we protested but not enough, we opposed them but not enough..." 


We Lived Happily During the War

is an award-winning psychiatrist who specialized in the cultural and ethical aspects of psychiatry, and is now in retirement and refirement as a private pro bono community psychiatrist. A prolific writer and speaker, he has done a weekday column titled “Psychiatric Views on the Daily News” and a weekly video, “Psychiatry & Society,” since the COVID-19 pandemic emerged. He was chosen to receive the 2024 Abraham Halpern Humanitarian Award from the American Association for Social Psychiatry. Previously, he received the Administrative Award in 2016 from the American Psychiatric Association, the one-time designation of being a Hero of Public Psychiatry from the Speaker of the Assembly of the APA in 2002, and the Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill in 1991. He is an advocate and activist for mental health issues related to climate instability, physician burnout, and xenophobia. He is now editing the final book in a 4-volume series on religions and psychiatry for Springer: Islamophobia, anti-Semitism, Christianity, and now

Do you have any recent experiences of awe? 

Hallelujah! A Series on Awe

Following a long path to approval, gepirone hydrochloride extended-release tablets (Exxua) is the first FDA-approved medication with this novel mechanism of action for adults with MDD.

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

The treatment, if approved, “will represent the first novel pharmacological approach to treating schizophrenia in several decades and provide a new treatment option for patients and their physicians.”

NDA Submitted for Investigational Muscarinic Antipsychotic in the Treatment of Schizophrenia

Advertise

Contact Us

Editorial

Terms and Conditions

Privacy Policy

Do Not Sell My Personal Information

Twitter

Facebook

LinkedIn

Spotlight

Expert Perspectives on the Clinical Management of Bipolar 1 Disorder

Expert Perspectives on the Unmet Needs in the Management of Major Depressive Disorder

Alex Colyer

Articles